Should I buy Clorox (CLX) stock or is it too late?

Clorox · Consumer Staples · price $104

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Evercore ISI Group — 69% of its targets hit on this sector (124 calls tested). It aims for $99 (-4.5 %), call made on August 5, 2026, maturing on August 5, 2027 (23 d ago).

The 6 reliable analysts $99.50-4.0 %

The 4 other firms $98-5.4 %

How to read it: the 6 reliable firms are not filtered by optimism — 1 aim above the price, 5 below, hence their $99.50 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Clorox

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Barclays	59 %	+7.9 %	27	$86 -17%
Morgan Stanley	53 %	-1.9 %	17	$110 +6%
Wells Fargo	43 %	-2.2 %	14	$102 -2%
JP Morgan	30 %	-8.4 %	10	$95 -8%
UBS	46 %	-9.4 %	13	$105 +1%
Credit Suisse	56 %	+2.5 %	9	—
DA Davidson	33 %	-7.4 %	6	—

In short — Should you invest in Clorox? Is it too late, still worth it? Analysts are split (0% buy, median target $100, i.e. -4%). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Pays a dividend (5.1% yield), raised for 22 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

Even the most reliable firm on CLX, Evercore ISI Group (75% hit rate, 4 scored calls), only targets $99 (call made on August 4, 2026, maturing on August 4, 2027) (-4%) in its most recent call, and $115 (call made on February 4, 2026, maturing on February 4, 2027) (+11%) in the one coming due soonest. The stock may already have run past its target.
The consensus is not unanimous: of 10 ratings, 7 are neutral and 3 are sells.
Limited upside: the median target is only -4% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on CLX

Median target $100 (-4%) · 10 ratings · Hold consensus

Strong Buy00%

Buy00%

Hold770%

Sell330%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Clorox now?

We won't decide for you. The facts: 0% of analysts rate it a buy, median target $100 (-4%), and Evercore ISI Group (most reliable on CLX, 75%) targets $99. Weigh that against valuation (P/E ~22). This is not personalized advice.

Is it too late to invest in Clorox?

The stated upside is small: the median target ($100) sits just -4% from the price ($104) (most reliable on CLX: Evercore ISI Group, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Clorox still worth investing in?

It depends on the gap between the price ($104) and its estimated value: analysts target $100 on median (-4%), with 0% buys (most reliable on CLX: Evercore ISI Group, 75%). Cross-check with their real reliability on CLX and the cautions above. Information, not advice.

What's the main risk in buying CLX?

Even the most reliable firm on CLX, Evercore ISI Group (75% hit rate, 4 scored calls), only targets $99 (call made on August 4, 2026, maturing on August 4, 2027) (-4%) in its most recent call, and $115 (call made on February 4, 2026, maturing on February 4, 2027) (+11%) in the one coming due soonest. The stock may already have run past its target.

→ Go deeper: the full Clorox profile (consensus, analyst reliability, price target, performance).